Epocrates Drug Updates — Editor’s Pick
June 24, 2009
New Drug Monograph for Nucynta
Nucynta (tapentadol), an oral mu opioid agonist and norepinephrine reuptake inhibitor, was recently approved for the treatment of acute moderate to severe pain in adult patients.
New Drug Monograph for Nucynta
Recent Updates
- June 17, 2009
- New Drug Monograph for Simponi
The tumor necrosis factor inhibitor Simponi (golimumab) was recently approved to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis in adult patients. New Drug Monograph for Simponi » - June 10, 2009
- New Warning for propylthiouracil
The FDA recently issued a MedWatch Safety Alert regarding the drug propylthiouracil (PTU) and the risk of serious liver injury, including liver failure and death. The FDA recommends that PTU be reserved for patients allergic to or intolerant of methimazole, or in their first trimester of pregnancy. Patients taking PTU should be carefully monitored for signs and symptoms of liver injury, especially in the first six months of therapy. New Warning for propylthiouracil » - June 3, 2009
- New Pediatric Indication for Axert
The FDA recently approved Axert (almotriptan) for the treatment of acute migraine in pediatric patients 12-17 years of age. New Pediatric Indication for Axert »
New Drug Monographs
RSS Feed
Top drug searchesThese updates, and hundreds more, are available in all Epocrates mobile and online products. See Products
To update your mobile reference, simply Update (sync). Learn How